Noteworthy, lurasidone was able to counteract the CRS-induced downregulation thus maintaining Gpx1 expression similar to the CTRL group (CRS/LUR: + 52% vs. CRS, P < 0.001). This evidence concerns the gene GPX1 and congenital rubella syndrome.